<ѻý>Novel Anti-Inflammatory Flops for HFpEF, HFmrEFѻý> Phase II trial does hold a few signals that might warrant another attempt Nov 18, 2024
<ѻý>Gene Therapy Promising for Rare Genetic Cardiomyopathyѻý> Phase I results show "big improvement" for what is usually progressive hypertrophy, expert says Nov 18, 2024
<ѻý>AI Can Do Whole Echo Reports, Improve Efficiencyѻý> AI transformation of the way cardiology uses echo "is absolutely going to happen, expert says Nov 17, 2024
<ѻý>Is DOAC a Viable Option After Bioprosthetic Valve Surgery Even in Sinus Rhythm?ѻý> Japanese trial supports use but event risk might be low enough to suggest a different strategy Nov 17, 2024
<ѻý>Novel CRISPR-Cas9-Based Promising in ATTR Cardiomyopathyѻý> One-time treatment with nexiguran ziclumeran tied to decline in serum TTR levels in phase I trial Nov 17, 2024
<ѻý>Tirzepatide Officially Puts GLP-1 Meds on the Map for Heart Failure Benefitѻý> SUMMIT trial able to show clinical benefit beyond quality-of-life improvement Nov 16, 2024
<ѻý>Post-Pandemic OHCA Survival Down; Vitamin D Supplements & BP; Varipulse PFA Approvedѻý> Recent developments of interest in cardiovascular medicine Nov 12, 2024
<ѻý>Inching Toward a Blood Test for Hypertrophic Cardiomyopathyѻý> Researchers try to address challenge of distinguishing HCM from other cardiomyopathies Nov 11, 2024
<ѻý>Tricuspid Valve Replacement Finds Surer Footing With TRISCEND II's 1-Year Reportѻý> Evoque device helped outcomes in severe tricuspid regurgitation, with some safety caveats Oct 31, 2024
<ѻý>Cold Weather Heart Attacks; Preemptive Valve Procedures Flop; Better Bleeding Scoreѻý> Recent developments of interest in cardiovascular medicine Oct 29, 2024
<ѻý>No Kidney Benefit With Finerenone in Heart Failure Patientsѻý> Anti-mineralocorticoid agent reduced albuminuria, but not eGFR-based kidney outcome Oct 28, 2024
<ѻý>Major Win for Preemptive TAVR in Symptomless Aortic Stenosisѻý> Larger pool of TAVR candidates suggested by EARLY TAVR trial results Oct 28, 2024
<ѻý>Private Equity's Tighter Grip; ApoB Inhibitors vs Liver? Promising New RDN Systemѻý> Recent developments of interest in cardiovascular medicine Oct 22, 2024
<ѻý>COVID's Outsized Heart Risk; Prehab for Cardiac Surgery; Telerobotic Valve Repairѻý> Recent developments of interest in cardiovascular medicine Oct 15, 2024
<ѻý>Safety Data Favor Diuretic Strategy Triggered by Cardiac Monitoring Alerts in HFѻý> Effectiveness of this personalized approach now under investigation Oct 11, 2024
<ѻý>Elamipretide for Barth Syndrome Survives FDA Advisory Voteѻý> Panelists acknowledge difficulty generating stronger data in ultra-rare disease Oct 11, 2024
<ѻý>FDA Reviewers Cast Doubt on Drug Candidate for Barth Syndromeѻý> Agency appears unswayed by mitochondria-targeting drug for rare cardioskeletal disease Oct 09, 2024
<ѻý>Prime Locations for AEDs; Fluctuating Lp(a); Formalized Telestroke Training?ѻý> Recent developments of interest in cardiovascular medicine Oct 08, 2024
<ѻý>Metabolic Accelerator Shows Promise for Weight Loss Side of Obesity-HFpEF Equationѻý> Benefit in symptoms, functional outcomes remains to be seen for HU6 Oct 02, 2024
<ѻý>VR Headsets in Cath Lab; ICDs & Driving Rules; How Cardiologist Got to Spaceѻý> Recent developments of interest in cardiovascular medicine Oct 01, 2024
<ѻý>Mavacamten Shows Promise in Heart Failure With Normal to Supranormal EFѻý> Cardiac myosin inhibitor linked to improvements in biomarkers in small study Sep 30, 2024
<ѻý>Case Strengthens for Cardiac Myosin Inhibitor in SEQUOIA-HCMѻý> Vast majority of trial participants responded to aficamten Sep 30, 2024
<ѻý>Does Finerenone's Efficacy Diminish if Initiated Late in Heart Failure?ѻý> Benefit of the nonsteroidal MRA otherwise consistent across FINEARTS-HF Sep 29, 2024
<ѻý>Tragus Stimulation for High BP; House Passes HEARTS Act; Risk in Pregnancy Surrogacyѻý> Recent developments of interest in cardiovascular medicine Sep 24, 2024
<ѻý>Reconsider When a Prophylactic ICD Is Needed in Nonischemic Dilated Cardiomyopathyѻý> Meta-analysis holds LGE higher than LVEF in identifying high-risk NIDCM Sep 20, 2024
<ѻý>Lp(a) Cutoffs by Sex; LBBA Pacing Approvals; Loneliness Not to Blame for CVD?ѻý> Recent developments of interest in cardiovascular medicine Sep 17, 2024
<ѻý>Are Regulators the Root of the Problem of Serious Device Recalls?ѻý> Study lays out common gaps in evidence both before and after approval Sep 16, 2024
<ѻý>Defibrillator Positioning; PFA for PVC Ablation; Harvey Weinstein's Heart Surgeryѻý> Recent developments of interest in cardiovascular medicine Sep 10, 2024
<ѻý>Oral Anticoagulation and TAVR Together: A Recipe for Troubleѻý> Continued OAC failed to meet noninferiority in POPular PAUSE TAVI Sep 03, 2024
<ѻý>TAVR's Win in Women; Chest Pressure During Cardioversion; Doc Goes to Spaceѻý> Recent developments of interest in cardiovascular medicine Sep 03, 2024
<ѻý>Nonsteroidal MRA Improves Outcomes in HFpEF, HFmrEFѻý> Randomized trial shows benefits beyond heart failure with low ejection fraction, but not survival Sep 01, 2024
<ѻý>Stenting, TAVR Make Sense Packaged Together for Some Patientsѻý> NOTION-3 trial informs care for those with severe AS and stable CAD Sep 01, 2024
<ѻý>Another Trial Sides With MitraClip for Functional Mitral Regurgitationѻý> RESHAPE-HF2 has provocative implications for a wider pool of TEER candidates Aug 31, 2024
<ѻý>TriClip's 'Soft' Benefits Affirmed in Severe Tricuspid Regurgitationѻý> Randomized trial "highly encouraging" for making patients feel and function better Aug 31, 2024
<ѻý>Pause or Keep RAS Inhibitors Before Surgery? Take Your Pick.ѻý> Either choice is "acceptable" based on randomized study Aug 31, 2024
<ѻý>Amyloidosis Drug Improves Outcomes, Survivalѻý> RNA silencer impresses with results in transthyretin amyloidosis cardiomyopathy Aug 30, 2024
<ѻý>Clot Grabber IFU Recall; Free Cholesterol Tests at CVS; Naloxone for Cardiac Arrestsѻý> Recent developments of interest in cardiovascular medicine Aug 27, 2024
<ѻý>Cardiologist’s Date Rape Verdict; Feds Come Down on DOAC Price; POC Test for HF?ѻý> Recent developments of interest in cardiovascular medicine Aug 20, 2024
<ѻý>Bleeding Better Controlled When Protamine Is Part of TAVR Wrap-Up Routineѻý> ACE-PROTAVI trial tested upfront vs selective use of heparin reversal agent Aug 14, 2024
<ѻý>SGLT2 Hesitance; Furosemide's Indication Grows; Legal Fight Over Entresto Genericѻý> Recent developments of interest in cardiovascular medicine Aug 13, 2024